Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma

Cytopathology

Volumn 13, Issue 1, 2002, Pages 11-21

  Sviatoha, V ^a   Rundgren, A ^b   Tani, E ^b   Hansson, J ^b   Kleina, R ^a   Skoog, L ^b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Bcl 2; CD40; CD44; FNA; Ki 67; Melanoma; Proliferation

Indexed keywords

CD40 ANTIGEN; CELL SURFACE RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD40; ANTIGENS, CD44; BIOPSY, NEEDLE; CELL COUNT; CELL DIVISION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036224150     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2002.00376.x     Document Type: Article

References (35)

1. Immunohistochemical marker for distinguishing Spitz nevi from malignant melanomas
2. MIB-1 Proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas
3. Prognostic value of biomarkers in malignant melanoma
4. Update of diagnostic and prognostic markers in cutaneous melanoma
5. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma
6. Adhesion molecules and tumor metastasis
7. Inhibition of human melanoma growth and metastasis in vivo by Anti-CD44 monoclonal antibody
8. CD40 and epithelial cells: Across the great divide
9. Functional role of CD40 and its ligand
10. CD40 is a prognostic marker in primary cutaneous malignant melanoma
11. CD44 is the principal cell surface receptor for hyaluronate
12. CD44 structure, function and assotiation with the malignant process
13. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44
14. Expression of CC44 variant isoforms in malignant melanoma
15. CD44 expression in benign and malignant nevomelanocytic lesions
16. Cell death signal transduction and Bcl-2 function
17. Bcl-2 and Bcl-2-related proteins in apoptosis regulation
18. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
19. Human melanocytes and melanoma ells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture
20. Bcl-2 protein expression in melanocytic neoplasms of the Skin
21. Bcl-2 expression in malignant melanoma and its prognostic significance
22. Expression of apoptosis regulators in cutaneous malignant melanoma
23. Aspiration biopsy cytology. Cytology of supradiaphragmatic organs'
24. Immunocytochemical analysis and cytomorphologic diagnosis on fine-needle aspirates of lymphoproliferative diseases
25. Cytomorphology and immunocytochemistry of fine-needle aspirates from blastic Non-Hodgkin's lymphomas
26. The developmental biology of primary human malignant melanomas
27. Thickness, cross-sectional areas and depth of invasion in the prognosis cutaneous melanoma
28. A new variant of glycoprotein CD44 confers metastatic potential of rat carcinoma cell
29. MIB-1 and S-phase specific cell fraction predicts survival in non-Hodgkin's lymphomas
30. Cell proliferation markers in predicting metastases in malignant melanoma
31. A computerised mathematical model and scoring system for predicting outcome in melanoma patients
32. Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation Markers
33. Melanoma epidemiology
34. Etiology, epidemiology, risk factors and public health issues of melanoma
35. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy